| [1] |
Hoch W, McConville J, Helms S, et al. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies[J]．Nat Med，2001，7(3):365-368.
|
| [2] |
Higuchi O, Hamuro J, Motomura M，et al.Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis[J]．Ann Neurol，2011，69(2):418-422.
|
| [3] |
Zhang B, Tzartos JS, Belimezi M，et al.Autoantibodies to lipoprotein related protein 4 in patients with double-seronegative myasthenia gravis[J]．Arch Neurol，2012，69(4):445-451.
|
| [4] |
Pevzner A, Schoser B, Peters K，et al.Anti-LRP4 autoantibodies in AChR and MuSK antibody-negative myasthenia gravis[J]．Neurol，2012，259(3):427-435.
|
| [5] |
Zhang B, Shen C, Bealmear B, et al. Autoantibodies to agrin in myasthenia gravis patients[J]．PLoS One，2014，9(3):e91816.
|
| [6] |
王述进，刘旭峰，黎国红．类风湿性关节炎合并强直性脊柱炎临床诊断特征分析[J/CD]．中华诊断学电子杂志，2015，3(1):52-53.
|
| [7] |
Gilhus NE, Skeir GO, Romi F. Myasthenia gravis-autoantibody characteristics and their implications for therapy[J]．Nat Rev Neurol，2016，12(5):259-268.
|
| [8] |
Gilhus NE.Autoimmune myasthenia gravis[J]．Expert Rev Neurother，2009，9(3): 351-358.
|
| [9] |
Jaretzki A, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis：recommendations for clinical research standards.Task force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America[J]．Neurology，2000，55(1):16-23.
|
| [10] |
Mao ZF, Yang LX, Mo XA，et al.Frequency of autoimmune diseases in myasthenia gravis: a systematic review[J]．Int J Neurosci，2011，121(3):121-129.
|
| [11] |
Gilhus NE, Nacu A, Andersen JB，et al.Myasthenia gravis and risks for comorbidity [J]．Eur J Neurol，2015，22(1):17-23.
|
| [12] |
Ragheb S, Lisak R, Lewis R, et al. A potential role for B cell activating factor in the pathogenesis of autoimmune myasthenia gravis[J]．Arch Neurol，2008，65(10):1358-1362.
|
| [13] |
Hong YH, Sung JJ. Auto-reactive B cells in MuSK myasthenia gravis[J]．Neuroimmunol Neuroinflammation，2016，3(8):196-197.
|
| [14] |
宋敏，丁晓君，岳耀先，等．B细胞活化因子基因多态性与重症肌无力的相关性研究[J]．中华神经内科杂志，2015，48(7):585-590.
|
| [15] |
Cheema GS, Roschke V, Hilbert DM, et al. Elevated serum B lymphocyte stimulator levels in patients with systemic immune based rheumatic diseases[J]．Arthritis Rheum，2001，44(6):1313-1319.
|
| [16] |
Meriggioli MN, Sanders DB. Muscle autoantibodies in myasthenia gravis：beyond dagnosis [J]．Exp Rev Clin Immunol，2012，8(5):427-438.
|
| [17] |
Evoli A, Tonali PA, Padua L，et al.Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis[J]．Brain，2003，126(Pt10):2304-2311.
|
| [18] |
Verschuuren JJ, Palace J, Gilhus NE.Clinical aspects of myasthenia explained[J]．Autoimmunity，2010，43(5-6):344-352.
|
| [19] |
Ohta K, Shigemoto K, Kubo S, et al. MuSK Ab described in seropositive MG sera found to be Ab to alkaline phosphatase[J]．Neurology，2005，65(12):1988.
|
| [20] |
母艳蕾，张华，国红，等．AchR及MuSK双抗体阳性重症肌无力三例并文献复习[J]．中国神经免疫学和神经病学杂志，2018，25(2):80-86.
|
| [21] |
Poulas K, Koutsouraki E, Kordas G，et al.Anti-MuSK and anti-AChR-positive myasthenia gravis induced by d-penicilamine[J]．Neuroimmunol，2012，250(1-2):94-98.
|
| [22] |
Zouvelou V, Kyriazi S, Rentzos M，et al.Double-seroposifive myasthenia gravis[J]．Muscle Nerve，2013，47(3):465-466.
|
| [23] |
Kawakami Y, Ito M, Hirayama M，et al.Anti-MuSK autoantibodies block binding of collagen Q to MuSK[J]．Neurology，2011，77(20):1819-1826.
|
| [24] |
Romi F, Hong Y, Gilhus NE.Pathophysiology and immunological profile of myasthenia gravis and its subgroups[J]．Curr Opin Immunol，2017(49):9-13.
|
| [25] |
王巍炜，梁芙茹，郝洪军，等．重症肌无力患者血清Ryanodine受体抗体检测及意义[J]．中华神经免疫学和神经病学杂志，2007，14(1):40-42.
|
| [26] |
Provenzano C, Marino M, Scuderi F，et al.Anti-acetylcholinesterase antibodies associate with ocular myasthenia favis[J]．J Neuroimmunol，2010，218(1-2):102-106.
|
| [27] |
Bryant A, Atkins H, Pringle CE，et al.Myasthenia gravis treated with autologous hematopoietic stem cell transplantation[J]．JAMA Neurol，2016，73(6):652-658.
|
| [28] |
Horváth B, Huizinga J, Pas HH，et al.Low-dose rituximab is effective in pemphigus[J]．Br J Dermatol，2012，166(2):405-412.
|
| [29] |
Fang F, Sveinsson O, Thormar G，et al.The autoimmune spectrum of myasthenia gravis：a Swedish population-based study[J]．Intern Med，2015，277(5):594-604.
|
| [30] |
Eker A, Tnazl M, Mut SE. Coexistence of anti-MuSK antibody-positive myasthenia gravis and rheumatoid arthritis[J]．Egypt J Neurol Psychiatr Neurosurg，2020，56(1):362-368.
|